Composition comprising at least one oxazoline for inhibiting langerhans cell migration, and uses thereof
    20.
    发明授权
    Composition comprising at least one oxazoline for inhibiting langerhans cell migration, and uses thereof 有权
    包含至少一种用于抑制朗格汉斯细胞迁移的恶唑啉的组合物及其用途

    公开(公告)号:US08236836B2

    公开(公告)日:2012-08-07

    申请号:US10499976

    申请日:2002-12-27

    Abstract: The invention concerns a composition containing at least an oxazolin, optionally combined with at least a compound such as a metalloprotease inhibitor, a PKC inhibitor, an anti-inflammatory agent, a soothing agent, an immunosuppressor, an ion chelating agent, an alkanolamide, an oxazolidinone and a carbamic acid derivative. The invention also concerns the use of such a composition as medicine, in particular for preventing or treating skin pathologies of allergic and/or inflammatory and/or irritative origin or resulting from a danger signal. The invention further concerns a method for cosmetic treatment of sensitive, irritated, intolerant, allergy-prone, ageing skin and/or mucosa exhibiting skin barrier disorder, or exhibiting non-pathological immunologic imbalance, which consists in applying such composition on the skin and/or mucosa.

    Abstract translation: 本发明涉及至少含有恶唑啉的组合物,任选地与至少一种化合物如金属蛋白酶抑制剂,PKC抑制剂,抗炎剂,舒缓剂,免疫抑制剂,离子螯合剂,链烷醇酰胺, 恶唑烷酮和氨基甲酸衍生物。 本发明还涉及使用这种组合物作为药物,特别是用于预防或治疗过敏和/或炎性和/或刺激性起源或由危险信号引起的皮肤病理学。 本发明还涉及一种用于美容治疗敏感的,刺激的,不耐受的,过敏倾向的,老化的皮肤和/或表现皮肤屏障障碍的皮肤或/或表现出非病理性免疫不平衡的皮肤和/或粘膜的方法,其包括在皮肤和/ 或粘膜。

Patent Agency Ranking